Thursday, June 2, 2016

BRIEF-Summit Therapeutics says Ridinilazole being prepared to enter Phase 3 trials

* Summit Therapeutics reports financial results for the

first quarter ended 30 April 2016 and operational progress

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)